PL3424911T3 - Pozakonazol, kompozycja, związek pośredni, sposób ich wytwarzania i ich zastosowania - Google Patents

Pozakonazol, kompozycja, związek pośredni, sposób ich wytwarzania i ich zastosowania

Info

Publication number
PL3424911T3
PL3424911T3 PL16892084T PL16892084T PL3424911T3 PL 3424911 T3 PL3424911 T3 PL 3424911T3 PL 16892084 T PL16892084 T PL 16892084T PL 16892084 T PL16892084 T PL 16892084T PL 3424911 T3 PL3424911 T3 PL 3424911T3
Authority
PL
Poland
Prior art keywords
posaconazole
preparation
composition
method therefor
therefor
Prior art date
Application number
PL16892084T
Other languages
English (en)
Inventor
Zhiguo Zheng
Original Assignee
Zhejiang Ausun Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Ausun Pharmaceutical Co., Ltd. filed Critical Zhejiang Ausun Pharmaceutical Co., Ltd.
Publication of PL3424911T3 publication Critical patent/PL3424911T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/22Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/26Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL16892084T 2016-03-04 2016-03-04 Pozakonazol, kompozycja, związek pośredni, sposób ich wytwarzania i ich zastosowania PL3424911T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2016/075594 WO2017147893A1 (zh) 2016-03-04 2016-03-04 泊沙康唑、组合物、中间体及其制备方法和用途
EP16892084.1A EP3424911B1 (en) 2016-03-04 2016-03-04 Posaconazole, composition, intermediate, preparation method therefor, and uses thereof

Publications (1)

Publication Number Publication Date
PL3424911T3 true PL3424911T3 (pl) 2022-01-03

Family

ID=59743359

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16892084T PL3424911T3 (pl) 2016-03-04 2016-03-04 Pozakonazol, kompozycja, związek pośredni, sposób ich wytwarzania i ich zastosowania

Country Status (9)

Country Link
US (1) US10696643B2 (pl)
EP (1) EP3424911B1 (pl)
JP (1) JP6938831B2 (pl)
KR (2) KR102434471B1 (pl)
DK (1) DK3424911T3 (pl)
ES (1) ES2893793T3 (pl)
PL (1) PL3424911T3 (pl)
SI (1) SI3424911T1 (pl)
WO (1) WO2017147893A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3353169B1 (en) * 2015-09-23 2023-03-15 Biocon Limited Crystalline forms of posaconazole intermediate and process for the preparation of amorphous posaconazole
CN114591272B (zh) * 2022-03-18 2024-04-05 浙江奥翔药业股份有限公司 作为合成泊沙康唑的中间体化合物的制备方法及其制备的中间化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403937A (en) * 1993-04-30 1995-04-04 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
PL181193B1 (pl) * 1993-12-21 2001-06-29 Schering Corp Nowe pochodne tetrahydrofuranowe o działaniu przeciwgrzybicznym, kompozycja farmaceutyczna do leczenia infekcji grzybiczych oraz sposób wytwarzania tych związków
WO2009141837A2 (en) 2008-05-21 2009-11-26 Ind-Swift Laboratories Limited Process for preparing posaconazole and intermediates thereof
WO2011158248A2 (en) * 2010-05-12 2011-12-22 Glenmark Generics Limited Process for preparation of posaconazole and crystalline polymorphic form v of posaconazole
CN101824009A (zh) * 2010-05-27 2010-09-08 北京德众万全药物技术开发有限公司 一种泊沙康唑及其哌嗪中间体的简单制备方法
US8273917B2 (en) * 2010-07-27 2012-09-25 Sci Pharmtech, Inc. Method for preparing chiral baclofen
DE102011106564A1 (de) * 2011-07-05 2013-01-10 Mahle International Gmbh Verfahren zur Herstellung einer Zylinderlauffläche sowie Zylinderlaufbuchse
US9102664B2 (en) 2011-09-19 2015-08-11 Msn Laboratories Private Limited Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof
WO2015059716A2 (en) * 2013-10-22 2015-04-30 Msn Laboratories Private Limited Improved process for the preparation of ((3s,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl-4-methylbenzenesulfonate
CN105503765B (zh) * 2014-09-26 2019-03-12 浙江奥翔药业股份有限公司 泊沙康唑、组合物、中间体及其制备方法和用途

Also Published As

Publication number Publication date
WO2017147893A1 (zh) 2017-09-08
EP3424911B1 (en) 2021-07-28
SI3424911T1 (sl) 2021-11-30
ES2893793T3 (es) 2022-02-10
EP3424911A4 (en) 2019-10-30
EP3424911A1 (en) 2019-01-09
JP6938831B2 (ja) 2021-09-22
DK3424911T3 (da) 2021-10-11
KR20200131347A (ko) 2020-11-23
US10696643B2 (en) 2020-06-30
KR20180115329A (ko) 2018-10-22
KR102434471B1 (ko) 2022-08-19
US20190071408A1 (en) 2019-03-07
JP2019507189A (ja) 2019-03-14

Similar Documents

Publication Publication Date Title
ZA201906131B (en) Herbicidal mixture, composition and method
EP3130354A4 (en) Posaconazole pharmaceutical composition and preparation method, application and pharmaceutical preparation thereof
SG11201802191XA (en) Makeup composition having reduced transfer, and preparation method therefor
GB201705124D0 (en) Composition, method and use
GB201705095D0 (en) Composition and methods and uses relating thereto
GB2564511B (en) Composition, method and use
IL262929B1 (en) Preparations for treatment, methods of their preparation and their uses
SG11202007554TA (en) Dioxazoline compound, preparation method therefor, and uses thereof
ZA201805600B (en) Pyrimidine seven-membered-ring compounds, preparation method therefor, pharmaceutical composition thereof, and uses thereof
GB201616657D0 (en) Methods, compositions and uses relating thereto
GB201520255D0 (en) Composition and method
GB201715768D0 (en) Methods, compositions and uses relating thereto
GB201706349D0 (en) Methods, compositions and uses relating thereto
GB201412213D0 (en) Material,composition and method
GB201616670D0 (en) Methods, compositions and uses relating thereto
ZA201904328B (en) Composition, application thereof and treatment method
EP3146968A4 (en) K2 composition, preparation method therefor, and application thereof
GB201805016D0 (en) Composition, method and use
SG10201603101YA (en) Lubricant composition, and preparation method and use thereof
GB201700116D0 (en) Method and composition
GB201509420D0 (en) Composition and method
SI3424911T1 (sl) Posakonazol, sestavek, intermediat, postopek priprave le-tega in uporabe le-tega
GB201616660D0 (en) Methods, compositions and uses relating thereto
GB201616666D0 (en) Methods, compositions and uses relating thereto
GB201616674D0 (en) Methods, compositions and uses relating thereto